The scavenger receptor CD36 is highly expressed on the apical side of enterocytes of the proximal intestine and on endothelial and immune cells throughout the organ. We previously documented the physiological role of CD36 in intestinal uptake of fatty acids (FA) and cholesterol and in promoting chylomicron synthesis. During this funding period, we made several novel observations. We found that CD36 is ubiquitinated on two C- terminal lysines, that ubiquitination is induced by FA and diglycerides and that it occurs during lipid absorption. The same C-terminal lysines were also found crucial for CD36's ability to transduce signals to the src kinase and downstream to the extracellular regulated kinase (ERK1/2). The CD36-ERK pathway is activated in a lipid- dependent manner during early stages of chylomicron formation. Furthermore we found that the src-ERK pathway is also involved in CD36-mediated regulation of the synthesis of arachidonic acid derived pro- inflammatory eicosanoids. Our hypothesis is that during early absorption the CD36-ERK signaling pathway functions to initiate in parallel chylomicron synthesis and an acute inflammatory response to dietary lipid. As digestion proceeds, luminal lipids down-regulate CD36 by inducing its ubiquitination and this feedback loop acts to limit inflammation. This hypothesis will be tested in aim 1. We will examine lipid regulation of ERK1/2 and triglyceride secretion in Caco-2 cells stably expressing CD36 or a mutant form with impaired signaling. Parallel studies will be conducted using intestinal segments and enterocytes from newly generated mice models with intestine-specific CD36 deletion (intCD36-/-) or rescue (intCD36+/+). Based on our new data showing CD36 dimerization and acetylation of the dimer, we will determine the role of these modifications in CD36 signaling and triglyceride secretion.
In aim 2 (A - C) we will examine the role of intestinal CD36 in influencing systemic metabolism, gut immune cells and lipid-induced inflammation using the intCD36-/- and intCD36+/+ mice. Our research approach will also involve a translational component (aim2D). We recently showed that common CD36 single nucleotide polymorphisms (SNPs) contribute to individual differences in fasting blood lipoproteins. The effects of several significant SNPs were related to alterations in CD36 protein expression (determined on monocyte and platelets). We now propose (aim 2D) to test impact of these expression SNPs (eSNPs) on postprandial lipids and on lipid-induced eicosanoid secretion and inflammation. Finally in aim 3 we will explore the mechanisms underlying our novel preliminary data demonstrating that CD36 deletion increases the bile acid pool, decreases bile hydrophobicity and effectively protects against gallstone formation. The findings generated from the work proposed should enhance our understanding of the absorptive function of a key metabolic protein. They should provide insight into the molecular steps involved in intestinal lipid processing and into how lipid processing interconnects with inflammation. We should learn whether targeting intestinal CD36 may be beneficial in disorders like obesity, insulin resistance and gallstone formation.

Public Health Relevance

We previously documented the physiological role of the membrane protein CD36 in intestinal uptake of fatty acids and cholesterol and in promoting chylomicron synthesis. Our recent data suggest additional roles of the protein in the inflammation induced by dietary lipid and in regulation of the biliary circulation. The work proposed should enhance our understanding of the absorptive functions of CD36, of the molecular steps involved in intestinal lipid processing and of how this interconnects with inflammation. We should learn whether targeting intestinal CD36 may be beneficial in disorders like obesity, insulin resistance and gallstone formation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK060022-12S1
Application #
8701522
Study Section
Clinical, Integrative and Molecular Gastroenterology Study Section (CIMG)
Program Officer
Maruvada, Padma
Project Start
2001-09-28
Project End
2017-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
12
Fiscal Year
2013
Total Cost
$250,057
Indirect Cost
$85,546
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Craft, Clarissa S; Pietka, Terri A; Schappe, Timothy et al. (2014) The extracellular matrix protein MAGP1 supports thermogenesis and protects against obesity and diabetes through regulation of TGF-?. Diabetes 63:1920-32
Clugston, Robin D; Yuen, Jason J; Hu, Yunying et al. (2014) CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis. J Lipid Res 55:239-46
Pepino, Marta Yanina; Bradley, David; Eagon, J Christopher et al. (2014) Changes in taste perception and eating behavior after bariatric surgery-induced weight loss in women. Obesity (Silver Spring) 22:E13-20
Huang, Stanley Ching-Cheng; Everts, Bart; Ivanova, Yulia et al. (2014) Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol 15:846-55
Ozdener, Mehmet Hakan; Subramaniam, Selvakumar; Sundaresan, Sinju et al. (2014) CD36- and GPR120-mediated Ca²? signaling in human taste bud cells mediates differential responses to fatty acids and is altered in obese mice. Gastroenterology 146:995-1005
Pietka, Terri A; Schappe, Timothy; Conte, Caterina et al. (2014) Adipose and muscle tissue profile of CD36 transcripts in obese subjects highlights the role of CD36 in fatty acid homeostasis and insulin resistance. Diabetes Care 37:1990-7
Kuda, Ondrej; Pietka, Terri A; Demianova, Zuzana et al. (2013) Sulfo-N-succinimidyl oleate (SSO) inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36 lysine 164: SSO also inhibits oxidized low density lipoprotein uptake by macrophages. J Biol Chem 288:15547-55
Nassir, Fatiha; Adewole, Okunade L; Brunt, Elizabeth M et al. (2013) CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice. J Lipid Res 54:2988-97
Kohli, Rohit; Bradley, David; Setchell, Kenneth D et al. (2013) Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab 98:E708-12
Sundaresan, Sinju; Shahid, Rafiq; Riehl, Terrence E et al. (2013) CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin. FASEB J 27:1191-202

Showing the most recent 10 out of 24 publications